103 related articles for article (PubMed ID: 8876383)
21. PD128,907 induces ocular hypotension in rabbits: involvement of D2/D3 dopamine receptors and brain natriuretic peptide.
Chu E; Socci R; Chu TC
J Ocul Pharmacol Ther; 2004 Feb; 20(1):15-23. PubMed ID: 15006155
[TBL] [Abstract][Full Text] [Related]
22. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
24. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
25. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol.
Inan UU; Ermis SS; Orman A; Onrat E; Yucel A; Ozturk F; Asagidag A; Celik A
J Ocul Pharmacol Ther; 2004 Aug; 20(4):293-310. PubMed ID: 15321024
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
27. Fadolmidine-induced ocular hypotension in normotensive rabbits.
Savolainen J; Niemi R; Mäntylä A; Huuskonen J; Järvinen T
J Pharm Pharmacol; 2005 Feb; 57(2):191-5. PubMed ID: 15720782
[TBL] [Abstract][Full Text] [Related]
28. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits.
Bonfiglio V; Bucolo C; Camillieri G; Drago F
Eur J Pharmacol; 2006 Mar; 534(1-3):227-32. PubMed ID: 16516192
[TBL] [Abstract][Full Text] [Related]
29. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
Stadtbäumer K; Frommlet F; Nell B
Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
[TBL] [Abstract][Full Text] [Related]
30. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
31. Potential sites of action of TNPA: a dopamine-2 receptor agonist.
Chu E; Chu TC; Potter DE
Exp Eye Res; 1999 Dec; 69(6):611-6. PubMed ID: 10620390
[TBL] [Abstract][Full Text] [Related]
32. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
[TBL] [Abstract][Full Text] [Related]
33. The effects of betaxolol hydrochloride ophthalmic solution on intraocular pressures during transient microgravity.
Pattinson TJ; Gibson CR; Manuel FK; Bishop SL; March WF
Aviat Space Environ Med; 1999 Oct; 70(10):1012-7. PubMed ID: 10519481
[TBL] [Abstract][Full Text] [Related]
34. Topical rivastigmine, a selective acetylcholinesterase inhibitor, lowers intraocular pressure in rabbits.
Goldblum D; Garweg JG; Böhnke M
J Ocul Pharmacol Ther; 2000 Feb; 16(1):29-35. PubMed ID: 10673128
[TBL] [Abstract][Full Text] [Related]
35. Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses.
Germann SE; Matheis FL; Rampazzo A; Burger D; Roos M; Spiess BM
Equine Vet J; 2008 Nov; 40(7):662-5. PubMed ID: 18487097
[TBL] [Abstract][Full Text] [Related]
36. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits.
Melena J; Santafé J; Segarra J
J Pharmacol Exp Ther; 1998 Jan; 284(1):278-82. PubMed ID: 9435188
[TBL] [Abstract][Full Text] [Related]
37. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
Christiansen GA; Nau CB; McLaren JW; Johnson DH
Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
[TBL] [Abstract][Full Text] [Related]
39. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
[TBL] [Abstract][Full Text] [Related]
40. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
Pang IH; Moll H; McLaughlin MA; Knepper PA; De Santis L; Epstein DL; Clark AF
Exp Eye Res; 2001 Dec; 73(6):815-25. PubMed ID: 11846512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
